Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 14 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 11278572

    Reducing CXCR4 expression and/or function to enhance engraftment of hematopoietic stem cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted

  2. US 11274077

    4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

    The United States of America Department of Health · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

  3. US 11273214

    Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and its use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

  4. US 11266692

    Intracellular genomic transplant and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted

  5. US 11266726

    Compositions and methods for the treatment of HER2-expressing solid tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted

  6. US 11268096

    Compounds for modulating Fc-epsilon-RI-beta expression and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted

  7. US 11253511

    Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)

    THE UNITED STATES OF AMERICA, as represented by th · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  8. US 11254735

    Prevention of tissue ischemia and related methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  9. US 11254662

    2′-halogenated-4′-thio-2′-deoxy-5-azacytidine analogs and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  10. US 11254667

    Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  11. US 11247971

    Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted

  12. US 11248039

    Immunoglobulin single variable domain antibody against RSV prefusion F protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted

  13. US 11246881

    Nanoparticle to target cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted

  14. US 11241436

    Autophagy inducers for treatment of CNS conditions

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted

  15. US 11243213

    Kits and methods for prediction and treatment of preeclampsia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted

  16. US 11236161

    Chimeric antigen receptors targeting CD-19

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  17. US 11236122

    Triterpene amine derivatives

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  18. US 11235054

    Multivalent vaccine composition

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  19. US 11236171

    Human monoclonal antibodies specific for FLT3 and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  20. US 11236151

    Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  21. US 11234953

    Ketone bodies to protect tissues from damage by ionizing radiation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  22. US 11236315

    Thermophile peptidoglycan hydrolase fusion proteins and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  23. US 11236152

    Neutralizing antibodies to HIV-1 GP41 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

  24. US 11235056

    Glycan-masked engineered outer domains of HIV-1 gp120 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.